Introducing New Members
- GYEMSZI (National Institute for Quality and Organizational Development in Healthcare and Medicines) - Hungary
- Dr. Noha Dashash - Saudi Arabia
- Dr. Mirrian Hilbink - Netherlands
- Dr. Pankaj Malhotra - India
- Dr. Monika Nothacker - Germany
- Dr. Matt Richardson - Sweden
New organisational members
Diagnostic Imaging Pathways (DIP) joined G-I-N in May this year and is an evidence-based and consensus-based education and decision support tool. The core of DIP is a suite of more than 150 pathways covering all of the organ systems. Each pathway is presented as a diagnostic flowchart which guides the user through appropriate diagnostic options associated with a particular clinical scenario or suspected pathology, and provides access to supporting information and source references. DIP is published electronically and is freely available at the following web-site - www.imagingpathways.health.wa.gov.au/
The process for producing, reviewing and updating DIP ensures compliance with the AGREE II Instrument and is published at the following site - www.imagingpathways.health.wa.gov.au/includes/production.html
The team responsible for DIP is working with other international teams to distribute the burden of guideline development, and is also working with a group of pathologists on the development of Diagnostic Imaging and Pathology Pathways. See page 7 for collaboration opportunity with DIP.
Being situated in the heart of Europe, the Grand Duchy of Luxembourg is bordered by Belgium, France, and Germany. The Luxembourgish health care system offers a comprehensive package of health services to 700.000 beneficiaries, composed of 500.000 residents and 200.000 cross-border workers.
In the frame of the latest health care reform, the "Cellule d’expertise médicale" (CEM) was established in 2011 as a publicly funded, independent, interministerial HTA organisation under the authority of the Ministry of Social Security. Its aims are:
- to technically and scientifically support the further development of the national medical classification and tariff systems
- to assess the effectiveness, quality and economic efficiency of selected diagnostic and therapeutic interventions based on scientific evidence
- to collaborate with the national scientific council on the elaboration, regular adaptation and implementation of evidence-based clinical practice guidelines
In its current inception phase, CEM has five staff members, of which two are medical doctors and one a health economist by training. It gains further administrative and technical support regarding legal, bio-statistical and medical know-how from other public departments.
CEM works on demand of the Ministries of Health and Social Security as well as of the national health insurance. At international level, CEM joined
- EUnetHTA in June 2011
- INAHTA in June 2012
- G-I-N in August 2012
For further information, see: www.mss.public.lu/acteurs/igss/cem/index.html
Iranian Center for Evidence-Based Medicine was the first established Iranian center for EBM in 2004 at Tabriz University of Medical Sciences. The center was designed and developed by the initiatives of Professor Hajebrahimi and recruited members from various University departments.
The center has its reputation as one of the pioneers of EBM in Iran and has achieved its goals to introduce EBM in routine practice in teaching hospitals and outpatient clinics of Tabriz University of Medical Sciences and some collaborating medical centers. Adapting and developing national EBM clinical guidelines, Health technology assessments, EBM decision making and policy making, developing Clinical governance, introducing EBM Journal clubs in various clinical groups in the University, Publishing books including translated EBM related books, teaching EBM in various international, national, regional and local workshops are in the list of achievements by the center.
The center has strengthened its links with a number of EBM centers worldwide. The center owes these achievements to the dedication of the members and willingness to share their EBM experience with colleagues and students. A number of research activities are also supported by funding, granted to various researchers and clinicians in all specialty and sub-specialties of medicine.
The Royal Tropical Institute (KIT) in Amsterdam is an independent center of knowledge and expertise in the areas of international and intercultural cooperation, operating at the interface between theory and practice and between policy and implementation. The Institute contributes to sustainable development, health, poverty alleviation and cultural preservation and exchange. KIT has a diverse group of people working in the field of Development, Policy & Practice, which provides research, advice, capacity building and education on international health care, economic, social and institutional development, Biomedical Research which conducts health research, advises on capacity building for health research, and develops diagnostic tests for tropical diseases and KIT Information & Library Services, which works on international and development cooperation, and also provides information services to developing countries.
The Collaboration for Evidence Based healthcare in Africa, presently lead by KIT, is a network of Faculties of Medicine, Schools of Public Health and Ministries and NGOs that aim to support the existence of an African healthcare system in which both public health policies and individual patient care are based on informed and evidence-based decisions. The focus is on topics that are linked to the disease burden of the countries. The staff has a broad experience in the field of epidemiology, public health, training and capacity building of research methodology and EBM in Europe and Africa.
For further information, see: www.kit.nl
The Belgian Healthcare Knowledge Centre (KCE) is a federal institution. It was founded in 2002 and is active since 2003. It is headquartered in Brussels. The KCE has about 60 employees, of which 44 are researchers (physicians, health economists, data analysts, statisticians, etc).
The KCE produces studies and reports to advise the Belgian policymakers when deciding on health care and health insurance. It is not involved in making these decisions, neither in their implementation. Its role is to point the way to the best possible solutions. It does so in a context of optimal access to health care of high quality and taking into account increasing demand and budgetary limitations.
The KCE is active in three major research fields:
- Analysis of clinical practices and development of recommendations of good practice (Good Clinical Practice)
- Assessment of health technologies and drugs (Health Technology Assessment)
- Healthcare financing and organization (Health Services Research)
The KCE guidelines are developed in collaboration with experts from Belgian and international scientific associations and according to strict standards. These standards are described in the 'KCE Process notes for Good Clinical Practice', which are currently undergoing an update and will be available as a web book early 2013.
Since its existence, the KCE has developed over 60 guidelines on various topics, such as the treatment of dementia, osteoporosis, varicose veins, neck pain, the use of pacemakers, the screening and treatment of different types of cancer, etc. All of these reports can be downloaded from the KCE website - http://kce.fgov.be.